Fidelity Disruptive Medicine Fund (FMEDX) News & Overview - Discounting Cash Flows
FMEDX
Fidelity Disruptive Medicine Fund
FMEDX (NASDAQ)

FMEDX Fund Portfolio Allocation

General Overview

Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.
Sector & Industry Financial Services / Asset Management
IPO date April 16, 2020

FMEDX Latest News

Other Identifiers
CIK0000225322
ISINUS31641Q5577
CUSIPNone
Open11.28
Previous Close11.3
Volume0
Average Volume0
Day’s Range11.28 – 11.28
52 Week Range10.96-11.6
MA (50)11.340606
MA (200)11.340606
Market Cap43.22 Mil.
Shares Out.3.83 Mil.
Earnings Date
Beta
Last Dividend
EPS
PE
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us